SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Liliʻuokalani
| Patient | Liliʻuokalani |
|---|
| Date of birth | 1947-09-02 |
|---|
| Identifiers | MRN HR-ET024-SYN; SSN (made up) 000-24-3086 |
|---|
| Document date | 2026-05-18 |
|---|
| Author | Kealani Morrison-Takeda, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Nosebleed this morning. [S]
History of Present Illness
Liliʻuokalani, a 78-year-old woman who had a minor ischemic stroke two months ago and takes apixaban for paroxysmal atrial fibrillation, came the same day with a nosebleed. This morning, after blowing her nose, the left nostril bled steadily for about 15 minutes; it stopped when a member of her ʻohana had her sit forward and pinch the soft part of her nose for ten minutes, as the clinic's handout showed. She did not swallow much blood or vomit. The air in her bedroom has been dry from a fan running all night, and her nose has felt crusted for a week. This is her first nosebleed in years. She has had no other bleeding: no bruising, blood in the urine, black stools or bleeding gums. She takes apixaban twice daily and has not missed a dose, and she has taken no aspirin, ibuprofen or naproxen. She has had no new weakness, numbness or speech trouble. [S]
| Element | Detail |
|---|
| Onset | This morning, after blowing her nose |
| Location | Left nostril |
| Duration | About 15 minutes; stopped with ten minutes of firm pressure |
| Severity | Steady bleeding from the front of the nose; no blood down the throat |
| Context | Apixaban for four weeks; dry air from a fan at night; nasal crusting for a week |
| Modifying factors | Leaning forward and firm pressure stopped it |
| Associated signs and symptoms | No other bleeding, lightheadedness or new neurological symptoms |
Review of Systems
| System | Result | Finding |
|---|
| Ears, nose, mouth, and throat | Positive | Left nosebleed this morning; nasal crusting for a week; no blood in the throat |
| Hematologic | Negative | No bruising, bleeding gums, blood in the urine or black stools |
| Cardiovascular | Negative | No palpitations, chest pain or lightheadedness |
| Neurological | Negative | No new weakness, numbness, speech or vision change |
4 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily for 21 days, after a 325 mg loading dose in the emergency department | One tablet daily for 21 days | Oral route | 2026-03-16 to 2026-04-06 | completed | S |
| Clopidogrel 75 mg oral tablet, one tablet daily, after a 300 mg loading dose in the emergency department | One tablet daily | Oral route | 2026-03-16 to 2026-04-20 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-16 | active | S |
| Losartan 25 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-23 | active | S |
| Apixaban 5 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 2026-04-20 | active | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-05-18 | Body height | 160 | cm | S |
| 2026-05-18 | Body weight | 57.8 | kg | S |
| 2026-05-18 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 2026-05-18 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-05-18 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-05-18 | Heart rate | 78 | /min | S |
| 2026-05-18 | Respiratory rate | 16 | /min | S |
| 2026-05-18 | Body temperature | 36.6 | Cel | S |
| 2026-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-05-18 | Hemoglobin [Mass/volume] in Blood | 12.5 | g/dL | 11.6-15 g/dL | Normal | S |
| 2026-05-18 | Platelets [#/volume] in Blood by Automated count | 230 | 10*3/uL | 150-400 10*3/uL | Normal | S |
Physical Exam
Vital signs recorded on 2026-05-18; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Well and composed; blood pressure 128/76, pulse 78 and regular |
| Nose | With a nasal speculum and good light: dried blood and crusting over a prominent vessel on the left anterior septum (Kiesselbach's area); no active bleeding; right side normal; no posterior bleeding in the throat |
| Skin | No bruising or petechiae |
| Neurological | Speech fluent; face symmetric; no drift; right hand grip and fine finger movements normal |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Transient weakness and clumsiness of the right hand with word-finding difficulty, lasting about 20 minutes and fully resolved, the afternoon before the visit; suspected transient ischemic attack, ABCD2 score 5 (high risk); NIH Stroke Scale 0 | resolved | provisional |
G45.9 | S — Synthetic presenting problem; resolved into the stroke diagnosis when diffusion MRI showed a small infarct at the stroke clinic the next day. Not a claim about her real symptoms. |
| Minor ischemic stroke: a small acute infarct in the cortex of the left precentral gyrus (left middle cerebral artery territory) on diffusion MRI, embolic in pattern, with full recovery (NIH Stroke Scale 0); source found to be paroxysmal atrial fibrillation; synthetic modern episode linked to her documented death from a stroke | active | confirmed |
I63.412 | S — Synthetic modern diagnosis made at the stroke clinic the day after the visit; the 1917 cause of death remains D. |
| Hypertension: told of borderline readings in past years and not treated; 156/88 mmHg at intake | active | confirmed |
I10 | S — Synthetic risk factor; no blood pressure from her lifetime is recorded in the cited sources. |
| Paroxysmal atrial fibrillation found on 30-day ambulatory monitoring after the stroke (six episodes, the longest 3 hours 10 minutes; burden about 3%); CHA2DS2-VASc 6, HAS-BLED 2 | active | confirmed |
I48.0 | S — Synthetic finding on prolonged rhythm monitoring at five weeks. |
| Anterior nosebleed from the left side of the nasal septum four weeks after starting apixaban, stopped with pressure; hemoglobin unchanged; resolved | resolved | confirmed |
R04.0 | S — Synthetic intercurrent problem at an unscheduled visit; a common minor bleed on an anticoagulant, not a documented illness. |
Assessment and Plan
- Anterior nosebleed on apixaban (R04.0). A minor anterior nosebleed from a dry, crusted septum, stopped with pressure; hemoglobin 12.5 g/dL, unchanged from 12.7 before apixaban. This is not a reason to stop anticoagulation: her stroke risk without it (CHA2DS2-VASc 6) far outweighs the risk from a minor bleed. Silver nitrate cautery of the vessel was offered; she chose to try moisturizing first, and that is reasonable while the bleeding has stopped. [S]
- Petroleum jelly or saline gel inside the front of both nostrils twice daily, and a humidifier or a damp towel near the fan at night.
- If it bleeds again: sit up, lean forward and pinch the soft part of the nose firmly for 10 to 15 minutes without letting go to check.
- Go to the emergency department if it bleeds for more than 20 minutes despite pressure, runs down the throat, or makes her lightheaded.
- Continue apixaban 5 mg twice daily without missing doses; avoid aspirin, ibuprofen and naproxen.
- Cautery at the clinic, or an ear, nose and throat specialist, if it happens again.
- Paroxysmal atrial fibrillation on apixaban (I48.0). Regular pulse today. HAS-BLED 2; no modifiable bleeding risks other than avoiding anti-inflammatory medicines. [S]
Guideline basis: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (2023); Signs and Symptoms of Stroke (2026); Clinical Practice Guideline: Nosebleed (Epistaxis) (2020)
Follow-up: Nurse telephone call in three days. Three-month review in four weeks. Call 911 for any BE FAST sign. Next scheduled visit 2026-06-15: three-month review after the stroke: function, mood, blood pressure, apixaban safety and falls. [S]